Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
12/2013
12/25/2013EP2139882B1 3- substituted quinoline or quinoxaline derivatives and their use as phosphatidylinositol 3-kinase (pi3k) inhibitors
12/25/2013EP2007720B1 Benzamide derivatives as inhibitors of histone deacetylase
12/25/2013CN103476798A Complex in which an anti-cotinine antibody is bound to a binder material of cotinine and a binding substance, and a use therefor
12/25/2013CN103476768A 6,5-heterocyclic propargylic alcohol compounds and uses therefor
12/25/2013CN103476767A Heterocyclic compounds as PI3 kinase inhibitors
12/25/2013CN103476766A Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
12/25/2013CN103476765A Method of inhibiting hamartoma tumor cells
12/25/2013CN103476759A Substituted 4-aryl-n-phenyl-1,3,5-triazin-2-amines
12/25/2013CN103476757A Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (PDE10A)
12/25/2013CN103476756A 3-ureidoisoquinolin-8-yl derivatives
12/25/2013CN103476754A Adamantyl compounds
12/25/2013CN103468245A OLED material with carrier transmittability as well as preparation method and application thereof
12/25/2013CN103467455A Zinc compound two-photon absorption material having viable tissue development function and preparation method thereof
12/25/2013CN103467454A Spiro substituted compounds as angiogenesis inhibitors
12/25/2013CN103467453A Preparation method of omeprazole magnesium crude medicine
12/25/2013CN103467452A Benzamide compounds and application thereof
12/25/2013CN103467451A Preparation method for S-pantoprazole sodium
12/25/2013CN103467450A Novel organic electroluminescent (EL) material and application thereof in devices
12/25/2013CN103467449A Piperidine derivative, and preparation method and application thereof in preparation of halofuginone
12/25/2013CN103467448A 7-(3-amino-4-alcoxylimido-1-piperidyl)-1-[(1R, 2S)-2-fluoro-cyclopropyl] quinolone carboxylic acid compounds and preparation methods thereof
12/25/2013CN103467447A Novel organic electroluminescent (EL) material and application thereof in devices
12/25/2013CN103467446A Preparation method of imatinib mesylate alpha crystal form
12/25/2013CN103467445A Preparation method of alogliptin benzoate
12/25/2013CN103467392A Polyhalogenated pyrazinecarboxamide derivative and salts, preparation method and application thereof
12/25/2013CN102633781B N-alkyl group-3, 6-di-(2-quinoline) vinyl) carbazole and preparation method thereof
12/25/2013CN102408410B Method for extracting 1-methyl-2-(3-pyridyl) tetrahydropyrrole
12/25/2013CN102272120B Biologically active amides
12/25/2013CN101754962B N-azacyclic substituted pyrrole, imidazole, triazole and tetrazole derivatives as agonists of RUP3 or GPR119 for treatment of diabetes and metabolic disorders
12/25/2013CN101591329B Method for preparing chiral azelnidipine and acceptable salt thereof
12/25/2013CN101432277B Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
12/25/2013CN101100466B Non-reversible protein tyrosine phosphorus acylase inhibitor and its preparation and application
12/24/2013US8614331 Process for preparation of esomeprazole sodium of high chemical purity and new forms of esomeprazole sodium
12/24/2013US8614330 Substituted benz-azoles and methods of their use as inhibitors of RAF kinase
12/24/2013US8614328 4′-O-substituted isoindoline derivatives and compositions comprising and methods of using the same
12/24/2013US8614317 Sulfonamide derivatives of polycyclic dyes used for analytical applications
12/24/2013US8614243 Small-molecule modulators of Trp-p8 activity
12/24/2013US8614242 1-(heterocyclic carbonyl)-2-substituted pyrrolidines
12/24/2013US8614234 Compounds as tyrosine kinase modulators
12/24/2013US8614233 Cinnamoyl inhibitors of transglutaminase
12/24/2013US8614231 Immunosuppressor based on the blockage of TCR-Nck interaction
12/24/2013US8614229 Substituted indole derivatives and methods of use thereof
12/24/2013US8614217 Fungicide hydroximoyl-tetrazole derivatives
12/24/2013US8614206 Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
12/24/2013US8614201 Heterocyclic amides as modulators of TRPA1
12/24/2013CA2714181C Ampk modulators
12/24/2013CA2620472C Substituted benzimidazoles as kinase inhibitors
12/24/2013CA2617096C Macrocyclic inhibitors of hepatitis c virus
12/24/2013CA2605510C Inhibitors of microsomal triglyceride transfer protein and apo-b secretion
12/24/2013CA2567821C Quinazolinone derivatives useful as vanilloid antagonists
12/24/2013CA2565200C Raf modulators and methods of use
12/19/2013WO2013188724A1 Azetidine and piperidine compounds useful as pde10 inhibitors
12/19/2013WO2013188452A1 Compounds and methods of treating cancer
12/19/2013WO2013188381A1 Pyridinone and pyridazinone derivatives
12/19/2013WO2013188254A1 Phosphoramidic acid prodrugs of 5 - [5 - phenyl- 4 - (pyridin- 2 - ylmethylamino) quinazolin- 2 - yl] pyridine- 3 - sulfonamide
12/19/2013WO2013187689A1 Novel organic electroluminescent compounds and organic electroluminescent device comprising the same
12/19/2013WO2013187646A1 Piperidine derivatives for gpr119 agonist
12/19/2013WO2013187503A1 Glycine transporter inhibitor
12/19/2013WO2013187496A1 Aromatic heterocyclic compound
12/19/2013WO2013187466A1 Branched chain alkyl heteroaromatic ring derivative
12/19/2013WO2013186692A1 TRIAZOLONE COMPOUNDS AS mPGES-1 INHIBITORS
12/19/2013WO2013186229A1 Tnf -alpha modulating benzimidazoles
12/19/2013WO2013185353A1 Compound as wnt signaling inhibitor, composition, and use thereof
12/19/2013WO2013185284A1 Pyridinone and pyridazinone derivatives
12/19/2013US20130338368 Method for analysis of protein and analytical reagent
12/19/2013US20130338367 Pyrazole derivatives and pesticides
12/19/2013US20130338358 Method for producing di(arylamino)aryl compound and synthetic intermediate therefor
12/19/2013US20130338193 Chiral 1-(4-methylphenylmethyl)-5-oxo--pyrrolidine-2-carboxamides as inhibitors of collagen induced platelet activation and adhesion
12/19/2013US20130338190 Pharmaceutically acceptable salt of (e)-n-[4-[[3-chloro-4-(2-pyridylmethoxy)phenyl]amino]-3-cyano-7-ethoxy-6-quinolyl]-3-[(2r)-1-methylpyrrolidin-2-yl]prop-2-enamide, preparation method thereof, and medical use thereof
12/19/2013US20130338189 Crystal of anti-bacterial compound
12/19/2013US20130338187 Novel 1-(1-OXO-1,2,3,4-TETRAHYDROISOQUINOLIN-7-YL)Urea Derivatives As N-FORMYL Peptide Receptor Like-1 (FPRL-1) Receptor Modulators
12/19/2013US20130338171 Pharmaceutically Acceptable Salts of Quinolinone Compounds Having Improved Pharmaceutical Properties
12/19/2013US20130338170 Trpv1 antagonists including dihydroxy substituent and uses thereof
12/19/2013US20130338167 Tartrate salts of quinazoline based egfr inhibitors containing a zinc binding moiety
12/19/2013US20130338163 Vinyl-aryl derivatives for inflammation and immune-related uses
12/19/2013US20130338159 Bi-heteroaryl compounds as vps34 inhibitors
12/19/2013US20130338158 6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (s1p) receptor antagonist biological activity
12/19/2013US20130338155 Method for treating infections
12/19/2013US20130338154 Mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
12/19/2013US20130338148 Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
12/19/2013US20130338147 4,6-disubstituted aminopyrimidine derivatives as inhibitors of protein kinases
12/19/2013US20130338146 Multifunctional nitroxide derivatives and uses thereof
12/19/2013US20130338138 Azetidine and piperidine compounds useful as pde10 inhibitors
12/19/2013US20130338112 Compounds for the treatment of proliferative disorders
12/19/2013US20130338111 Sulfonamide Derivatives
12/19/2013US20130338105 Iminipyridine derivatives and their uses as microbiocides
12/19/2013US20130336965 Novel ring-substituted n-pyridinyl amides as kinase inhibitors
12/19/2013US20130336921 Compounds and methods for inhibiting phosphate transport
12/19/2013US20130336920 Compounds and methods for inhibiting phosphate transport
12/19/2013US20130336903 Personal Care Compositions Comprising a pH Tuneable Gellant and Methods of Using
12/19/2013CA2876359A1 Phosphoramidic acid prodrugs of 5 - [5 - phenyl- 4 - (pyridin- 2 - ylmethylamino) quinazolin- 2 - yl] pyridine- 3 - sulfonamide
12/19/2013CA2876249A1 Branched chain alkyl heteroaromatic ring derivative
12/19/2013CA2875802A1 Azetidine and piperidine compounds useful as pde10 inhibitors
12/19/2013CA2875372A1 Compound as wnt signaling inhibitor, composition, and use thereof
12/19/2013CA2875016A1 Pyridinone and pyridazinone derivatives
12/19/2013CA2874953A1 Pyridinone and pyridazinone derivatives
12/18/2013EP2674423A1 Pyrazole derivative and pest control agent
12/18/2013EP2674417A2 Biaryl PDE4 inhibitors for treating inflammation
12/18/2013EP2673270A1 Insecticidal compounds
12/18/2013EP2673269A1 Heterocyclic compounds as pi3 kinase inhibitors
12/18/2013EP2673268A1 Method of inhibiting hamartoma tumor cells
1 ... 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 ... 1080